DBV Technologies

Epidemiological studies suggest that over half of Americans are sensitive to at least one allergen. Environmental and lifestyle changes, urbanization, pollution, dietary changes, development of sanitation standards and decrease in chronic bacterial infections all are assumed to be factors promoting the rapid increase in prevalence of allergy throughout the developed world. Approximately 3% to 5% of Americans suffer from food allergies with a number of recent studies suggesting that approximately 8% of children have some type of food allergy. Recent studies suggest that patients with food allergies are especially at risk of experiencing significant disruption in their daily lives. Recent scientific studies suggest that treating allergies early in life could prevent disease progression or the development of polyallergies, however, no approved treatments currently exist for young allergic children.
Type
Public
HQ
Montrouge, FR
Founded
2002
Size (employees)
113 (est)
DBV Technologies was founded in 2002 and is headquartered in Montrouge, FR

Key People/Management at DBV Technologies

Pierre-Henri Benhamou

Pierre-Henri Benhamou

CEO & CSO
David Schilansky

David Schilansky

CFO
Bertrand Dupont

Bertrand Dupont

CTO
Charles Ruban

Charles Ruban

CDO

DBV Technologies Office Locations

DBV Technologies has offices in Montrouge and New York
Montrouge, FR (HQ)
181 Avenue Pierre Brossolette
New York, US
320 Park Ave

DBV Technologies Financials and Metrics

DBV Technologies Financials

EUR

Market capitalization (31-Oct-2017)

957.7 m

Closing share price (31-Oct-2017)

39.3
DBV Technologies's current market capitalization is €957.7 m.
Show all financial metrics

DBV Technologies Market Value History

DBV Technologies's Web-traffic and Trends

DBV Technologies Online and Social Media Presence

DBV Technologies Company Life and Culture

You may also be interested in